George J Chang

Colorectal cancer surgeon and health services researcher @MDAndersonNews. #EndCancer #OncSurgery

[George J Chang @ColonCancerDoc]

What honor to join @MDAndersonNews amazing team and so many dedicated supporters 4 @ColonCancerCoal #GYRIG 5k for #CRC. TY! @ARosen380 for inviting me to kick off the WOW! WOW! WOW! awesome event and spreading word about our #YOCRC program this morning! @NancyYouMD #OncSurgery

[Marivic @arieshorse]

Get Your Rear In Gear Houston! Colon Cancer Awareness 5k Run/Walk at Constellation Field - Sugar Land TX. @MDAndersonNews @ColonCancerDoc @drsmags @vseyer #EndCancer

[Ryan Huey, MD, MS @ryanhuey]

Great first session to #ASCOQLTY23. @BThomPhD highlights practice delivery changes that can reduce financial toxicity for patients - telehealth, coordinated appointments, standardizing surveillance. Spot on! @ColonCancerDoc

[George J Chang @ColonCancerDoc]

Excited to see publication of the great work by our @MDAndersonNews #OncSurgery #T32 fellow @NManisundaram from @BCM_Surgery highlighting this new @AmColSurgCancer #RCRS quality measure for #RectalCancer treatment and need for improvement in reporting it.

[JAMA Surgery @JAMASurgery]

Although circumferential resection margin (CRM) positivity reporting has improved over past decade, ¼ of Commission on Cancer facilities have missingness rates >16%. CRM missingness was associated with missingness in other pathologic measures. https://t.co/UFbPGrFYIb

[George J Chang @ColonCancerDoc]

I just made a donation to @MDAndersonNews’ @BootWalk to #endcancer. Donate to join the fight. https://t.co/owR4EKc1vd

[George J Chang @ColonCancerDoc]

@Averywalker21 @JohnRTMonsonMD @SWexner @DavidKleimanMD @jabelsonmd @EKing719 @DrE_UCSD @MarkSoliman @ASCRS_1 @skopetz Definitely would not start chemo now. PET can be done but not likely helpful. Best approach not yet clear but would re-image 3-6 months. For trials can register at https://t.co/T3xke6gtOf.

[John Monson MD FRCS FACS FASCRS @JohnRTMonsonMD]

This issue has the potential to open flood gates - maybe good, maybe bad! Near-complete response following neoadjuvant therapy in rectal cancer: wait a bit longer? https://t.co/GUq6yqCfwA @R_Perez_MD @DrGarciaAguilar @JoshSmithMDPhD @Dr_M_Tejani @ColonCancerDoc

[George J Chang @ColonCancerDoc]

@Averywalker21 @JohnRTMonsonMD @SWexner @DavidKleimanMD @jabelsonmd @EKing719 @DrE_UCSD @MarkSoliman @ASCRS_1 CEA and imaging can lag. With uptrending ctDNA, highly concerning for minimal residual disease and should re-image at shorter term intervals. Consider referral for MRD trials. @skopetz and our #INTERCEPT program are tackling.

[George J Chang @ColonCancerDoc]

@Neil_J_Smart @ArfonPowell Breakfast of champions!

[Jim Khan @JimkhanMD]

An absolute honour to be in #Barcelona for the #WCGIC2023 and talk about robotics in rectal cancer 😍@ColonCancerDoc @prof_gina_brown @R_Perez_MD @IntuitiveSurg @ACPGBI @ALSGBIAcademy @PColorectal @PHU_NHS

[UT MD Anderson @UTMDAnderson]

What is the most common type of anesthesia used for colonoscopies?

And what side effects can you expect?

Here, our Dr. Katherine Hagan answers common questions about colonoscopy anesthesia: https://t.co/AetttoeAY0 @katehagan1 #ColonCancer #EndCancer

[George J Chang @ColonCancerDoc]

@PrajnanDasMD @DrEmmaHolliday @eugenekoay @ebludmir @TaniguchiMD @SNoticewala @MDAndersonNews Looks like fun! Can our teams do the next one together?

[Adam Grant @AdamMGrant]

Leadership is not about pulling people to follow your path. It's about shining enough light for them to find their own route.

Bosses aim to wield power. They issue commands to maintain control.

Leaders strive to empower. They delegate authority to unleash potential.

[George J Chang @ColonCancerDoc]

@QDenost @tarik_sammour @PelvExGroup @des_winter @mekelly123 @DeenaHarji @TejedorPat @AaronQuyn @SatishWarrier @cherrykoh @GabrielleVanRam @Jordanfletch6 @evaangenete @BordeauxCI Miss everyone so much but can’t wait for PelvEx2024!

[George J Chang @ColonCancerDoc]

Don’t forget about a proper omental flap. Particularly when based on right gastroepiploic and including all the omentum to the diaphragm, can get great space filling, lymphatic drainage, and avoid morbidity of gluteal or rectus flaps! Does not require high BMI!

[John Monson MD FRCS FACS FASCRS @JohnRTMonsonMD]

@TAMISYoda @DCRjournal APER will never be morbidity free and post RT 1/3 have delayed healing which patients hate (RCT data). So, if radiated then always. Gluteal is easier and doesn’t sacrifice the remaining rectus. No free lunch anywhere here! @DrGarciaAguilar @juliomayol @ColonCancerDoc @cmf2x

[George J Chang @ColonCancerDoc]

Congratulations ⁦@MikeWhiteMD⁩ newest ⁦@MDAndersonNews⁩ Colon and Rectal #OncSurgery faculty on receiving the ⁦@WCGIC⁩ ⁦⁦@myESMO⁩ Young Investigator Award! Nothing better than seeing your new faculty more successful than you! ⁦@jpshen_md⁩

[George J Chang @ColonCancerDoc]

Important study 👇 led by @MDAndersonNews #YOCRC program and director @NancyYouMD highlights need for universal germline testing. 1 in 5 #CRC patients <50 yo harbored germline cancer predisposition. Another nearly 1 in 5 with VUS. #OncSurgery

[DCRjournal @DCRjournal]

#DCRJournal examines Germline CA Risk Profiles of Young-Onset #ColorectalCancer: https://t.co/BWpn87QvxW - what do you think about this visual abstract?

@ColonCancerDoc @MDAnderson @JISBMD @ConorDelaneyMD @justinmaykel @KarimAlavi @KyleCologne @dubaicolorectal @SamAtallahMD

[Jennifer Wargo MD @JenWargoMD]

Request for applications now open for our T32 Training Program in Surgical Oncology @MDAndersonNews with a fantastic team of faculty, staff and trainees including Dr. Funda Meric Bernstam @mkatzmd @CrisyRoland @emilykeungMD @EGrubbsMD @timnewhook19 and many more! #endcancer

[George J Chang @ColonCancerDoc]

Never know who you might meet striking through cancer at the⁩ #ASCO meeting! ⁦@ChrisRFlowersMD⁩ ⁦@MDAndersonNews⁩

[George J Chang @ColonCancerDoc]

@AHKuhnen @NancyYouMD @TomReadCRS @LaheyColoRectal @DavidLiskaMD @jabelsonmd @DavidKleimanMD Great news for our patients who now have good options for optimizing their treatment to minimize toxicity and align with their goals and preferences!

[George J Chang @ColonCancerDoc]

@JohnRTMonsonMD @MDAndersonNews @TAMISYoda @Leo708 @ASCRS_1 Still much to learn. 👍 growing recognition lateral node metastases should not be ignored or overlooked. Lateral dissection, whether based on pretreatment findings or selectively based on post treatment findings should be part of the management strategy. #OncSurgery